Hak Choy, MD
Simmons Cancer Center
5
1
3
N/A
0
1
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+5 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (5)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Aminah Jatoi, MD
Mayo Clinic
Shared therapeutic areas:
Worked with same sponsors:
Jeffrey A. Bogart, MD
State University of New York - Upstate Medical University
Shared therapeutic areas:
Worked with same sponsors:
Alex A. Adjei, MD, PhD
Roswell Park Cancer Institute
Shared therapeutic areas:
Worked with same sponsors:
Mark Dobelbower, MD PhD
University of Alabama Medical Center
Shared therapeutic areas:
Worked with same sponsors:
Gregory A. Masters, MD
CCOP - Christiana Care Health Services
Shared therapeutic areas:
Worked with same sponsors:
Steven E. Schild, MD
Mayo Clinic
Shared therapeutic areas:
Worked with same sponsors:
Tien Hoang, MD
University of Wisconsin, Madison
Shared therapeutic areas:
Worked with same sponsors:
Jeff Sloan, PhD, HSR
Mayo Clinic
Shared therapeutic areas:
Worked with same sponsors:
Ken Forster, PhD
H. Lee Moffitt Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
George Blumenschein, MD
M.D. Anderson Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
Publications (0)
No publications found for this investigator.
Clinical Trials (5)
Showing 5 of 5 trials
Nab-Paclitaxel, Cisplatin, and Cetuximab With Concurrent Radiation Therapy for Locally Advanced Head and Neck Cancer
Sorafenib and High-Dose Carboplatin, Paclitaxel, and External-Beam Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer
Gemcitabine, Carboplatin or Paclitaxel Plus Radiation Therapy in Treating Patients With Stage IIIA or IIIB Non-Small Cell Lung Cancer
Chemotherapy and Radiation Therapy With or Without Efaproxiral in Treating Patients With Stage III Non-Small Cell Lung Cancer
High-Dose or Standard-Dose Radiation Therapy and Chemotherapy With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
All 5 trials loaded